SCHEMBL8104626

SCHEMBL8104626

O=Cc1ccc(OCCC2CO2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
HPGD P15428 5/20 0.49
MAPT P10636 4/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
CYP2A6 P11509 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAB9A P51151 1/20 0.39
TP53 P04637 2/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
KMT2A Q03164 1/20 0.38
PPARG P37231 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27452158 0.90 ALDH1A1 (0.50) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL27390202 0.89 ALDH1A1 (0.49) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL11179281 0.86 TDP1 (0.50) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL3466095 0.83 ALDH1A1 (0.60) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL7694361 0.83 ALDH1A1 (0.60) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL8105528 0.83 ALDH1A1 (0.60) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL8338592 0.82 HPGD (0.65) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL8633351 0.82 ALDH1A1 (0.54) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL22065474 0.81 ALDH1A1 (0.44) ALDH1A1HPGDMAPTLMNASMN1; SMN2
SCHEMBL27950338 0.81 ALDH1A1 (0.53) ALDH1A1HPGDMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024071323-A1 COMPOSITION, OPTICALLY ANISOTROPIC LAYER, LAMINATE, METHOD FOR MANUFACTURING OPTICALLY ANISOTROPIC LAYER, AND LIQUID CRYSTAL COMPOUND 富士フイルム株式会社 2024-04-04 WO disclosed
EP-0605729-B1 OXAZOLIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2000-07-26 EP disclosed
US-5480899-A ANTILIPEMIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-01-02 US disclosed
EP-0605729-A1 OXAZOLIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 1994-07-13 EP disclosed